Correlation Between Putnam Biorevolution and Vanguard Consumer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Putnam Biorevolution and Vanguard Consumer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Putnam Biorevolution and Vanguard Consumer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Putnam Biorevolution ETF and Vanguard Consumer Staples, you can compare the effects of market volatilities on Putnam Biorevolution and Vanguard Consumer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Putnam Biorevolution with a short position of Vanguard Consumer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Putnam Biorevolution and Vanguard Consumer.

Diversification Opportunities for Putnam Biorevolution and Vanguard Consumer

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Putnam and Vanguard is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Putnam Biorevolution ETF and Vanguard Consumer Staples in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Consumer Staples and Putnam Biorevolution is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Putnam Biorevolution ETF are associated (or correlated) with Vanguard Consumer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Consumer Staples has no effect on the direction of Putnam Biorevolution i.e., Putnam Biorevolution and Vanguard Consumer go up and down completely randomly.

Pair Corralation between Putnam Biorevolution and Vanguard Consumer

Given the investment horizon of 90 days Putnam Biorevolution ETF is expected to under-perform the Vanguard Consumer. In addition to that, Putnam Biorevolution is 1.52 times more volatile than Vanguard Consumer Staples. It trades about -0.06 of its total potential returns per unit of risk. Vanguard Consumer Staples is currently generating about 0.37 per unit of volatility. If you would invest  21,314  in Vanguard Consumer Staples on September 4, 2024 and sell it today you would earn a total of  1,028  from holding Vanguard Consumer Staples or generate 4.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Putnam Biorevolution ETF  vs.  Vanguard Consumer Staples

 Performance 
       Timeline  
Putnam Biorevolution ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Putnam Biorevolution ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Putnam Biorevolution is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Vanguard Consumer Staples 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vanguard Consumer Staples are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Vanguard Consumer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Putnam Biorevolution and Vanguard Consumer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Putnam Biorevolution and Vanguard Consumer

The main advantage of trading using opposite Putnam Biorevolution and Vanguard Consumer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Putnam Biorevolution position performs unexpectedly, Vanguard Consumer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Consumer will offset losses from the drop in Vanguard Consumer's long position.
The idea behind Putnam Biorevolution ETF and Vanguard Consumer Staples pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals